Sanofi reportedly weighs takeover of US drugmaker Insmed
SNY•Sanofi is weighing an acquisition of Insmed, which has a market valuation of $26.28 billion. The deliberations are ongoing, and any deal could still be weeks away.
SNY•Sanofi is weighing an acquisition of Insmed, which has a market valuation of $26.28 billion. The deliberations are ongoing, and any deal could still be weeks away.
Sanofi is speaking with advisers as it studies a potential deal for Insmed, Bloomberg News reported, citing people familiar with the matter. Sanofi said it does not comment on market rumors.
The people said deliberations are ongoing and any deal could still be weeks away. Insmed shares were up 14%; the company did not immediately respond to a request for comment.